Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial
…, W Dankner, M Shelton, RF Jacobs, W Vaudry… - The Journal of …, 2003 - Elsevier
Objective To evaluate the efficacy and safety of ganciclovir therapy in neonates with congenital
cytomegalovirus (CMV) disease. Study design Neonates with symptomatic CMV disease …
cytomegalovirus (CMV) disease. Study design Neonates with symptomatic CMV disease …
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of …
…, D Tran, TM Uyeki, A Van Zwol, W Vaudry… - The lancet Respiratory …, 2014 - thelancet.com
Background Neuraminidase inhibitors were widely used during the 2009–10 influenza A H1N1
pandemic, but evidence for their effectiveness in reducing mortality is uncertain. We did a …
pandemic, but evidence for their effectiveness in reducing mortality is uncertain. We did a …
Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system
…, W Dankner, M Shelton, RF Jacobs, W Vaudry… - Journal of Clinical …, 2009 - Elsevier
BACKGROUND: Ganciclovir protects against hearing deterioration in infants with symptomatic
congenital cytomegalovirus (CMV) disease involving the central nervous system (CNS). …
congenital cytomegalovirus (CMV) disease involving the central nervous system (CNS). …
Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada
…, D Scheifele, B Smith, E Ford-Jones, W Vaudry… - The Journal of …, 2003 - Elsevier
OBJECTIVES: To describe the clinical course of fatal cases of pertussis and identify predictors
of death at the time of presentation for medical care. METHODS: Case-control study of 16 …
of death at the time of presentation for medical care. METHODS: Case-control study of 16 …
Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program—Active (IMPACT)
…, N MacDonald, T Jadavji, W Vaudry… - Clinical infectious …, 1999 - academic.oup.com
To assess the morbidity associated with the continued high levels of pertussis, we studied
all children .2 years of age who were admitted to the 11 Immunization Monitoring Program-…
all children .2 years of age who were admitted to the 11 Immunization Monitoring Program-…
Hospitalization for influenza A versus B
D Tran, W Vaudry, D Moore, JA Bettinger… - …, 2016 - publications.aap.org
BACKGROUND: The extent to which influenza A and B infection differs remains uncertain.
METHODS: Using active surveillance data from the Canadian Immunization Monitoring …
METHODS: Using active surveillance data from the Canadian Immunization Monitoring …
The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000–2007
…, DW Scheifele, JD Kellner, SA Halperin, W Vaudry… - Vaccine, 2010 - Elsevier
Active surveillance was conducted by the 12 centers of the Canadian Immunization Monitoring
Program, Active from 2000–2007 in children 16 years of age and younger to determine …
Program, Active from 2000–2007 in children 16 years of age and younger to determine …
A randomized controlled trial of the safety and immunogenicity of tetanus, diphtheria, and acellular pertussis vaccine immunization during pregnancy and subsequent …
…, N Le Saux, A Gruslin, W Vaudry… - Clinical Infectious …, 2018 - academic.oup.com
Background Immunization of pregnant women with tetanus-diphtheria-acellular pertussis
vaccine (Tdap) provides protection against pertussis to the newborn infant. Methods In a …
vaccine (Tdap) provides protection against pertussis to the newborn infant. Methods In a …
[HTML][HTML] The effect of the COVID-19 pandemic on influenza-related hospitalization, intensive care admission and mortality in children in Canada: A population-based …
…, R Purewal, P Déry, R Thibeault, W Vaudry… - The Lancet Regional …, 2022 - thelancet.com
Background The COVID-19 pandemic resulted in unprecedented implementation of wide-ranging
public health measures globally. During the pandemic, dramatic decreases in …
public health measures globally. During the pandemic, dramatic decreases in …
Outcomes of invasive meningococcal disease in adults and children in Canada between 2002 and 2011: a prospective cohort study
…, DW Scheifele, SA Halperin, W Vaudry… - Clinical Infectious …, 2015 - academic.oup.com
Background. Neisseria meningitidis causes 500 000 cases of septicemia and meningitis
worldwide annually, with approximately 200 cases in Canada each year. Previous studies …
worldwide annually, with approximately 200 cases in Canada each year. Previous studies …
